Literature DB >> 16508118

Crystallization and preliminary X-ray analysis of coagulation factor IX-binding protein from habu snake venom at pH 6.5 and 4.6.

Nobuhiro Suzuki1, Yasuo Shikamoto, Zui Fujimoto, Takashi Morita, Hiroshi Mizuno.   

Abstract

Coagulation factor IX-binding protein isolated from Trimeresurus flavoviridis (IX-bp) is a C-type lectin-like protein. It is an anticoagulant protein consisting of homologous subunits A and B. The subunits both contain a Ca2+-binding site with differing affinity (Kd values of 14 and 130 microM at pH 7.5). These binding characteristics are pH-dependent; under acidic conditions, the affinity of the low-affinity site was reduced considerably. In order to identify which site has high affinity and also to investigate the Ca2+-releasing mechanism, IX-bp was crystallized at pH 6.5 and 4.6. The crystals at pH 6.5 and 4.6 diffracted to 1.72 and 2.29 A resolution, respectively; the former crystals belong to the monoclinic space group P2(1), with unit-cell parameters a = 60.7, b = 63.5, c = 66.9 A, beta = 117.0 degrees, while the latter belong to the monoclinic space group C2, with a = 134.1, b = 37.8, c = 55.8 A, beta = 110.4 degrees.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16508118      PMCID: PMC1952379          DOI: 10.1107/S1744309104032439

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  9 in total

1.  The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E.

Authors:  H Atoda; M Hyuga; T Morita
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

2.  Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains.

Authors:  H Mizuno; Z Fujimoto; M Koizumi; H Kano; H Atoda; T Morita
Journal:  Nat Struct Biol       Date:  1997-06

3.  Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X.

Authors:  H Mizuno; Z Fujimoto; H Atoda; T Morita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Blood coagulation factor IX-binding protein from the venom of Trimeresurus flavoviridis: purification and characterization.

Authors:  H Atoda; M Ishikawa; E Yoshihara; F Sekiya; T Morita
Journal:  J Biochem       Date:  1995-11       Impact factor: 3.387

6.  Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region.

Authors:  H Mizuno; Z Fujimoto; M Koizumi; H Kano; H Atoda; T Morita
Journal:  J Mol Biol       Date:  1999-05-28       Impact factor: 5.469

7.  Arrangement of the disulfide bridges in a blood coagulation factor IX/factor X-binding protein from the venom of Trimeresurus flavoviridis.

Authors:  H Atoda; T Morita
Journal:  J Biochem       Date:  1993-02       Impact factor: 3.387

8.  Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein.

Authors:  Yasuo Shikamoto; Takashi Morita; Zui Fujimoto; Hiroshi Mizuno
Journal:  J Biol Chem       Date:  2003-04-14       Impact factor: 5.157

9.  Role of calcium(II) ions in the recognition of coagulation factors IX and X by IX/X-bp, an anticoagulant from snake venom.

Authors:  F Sekiya; T Yamashita; T Morita
Journal:  Biochemistry       Date:  1995-08-08       Impact factor: 3.162

  9 in total
  1 in total

1.  Venomics and Cellular Toxicity of Thai Pit Vipers (Trimeresurus macrops and T. hageni).

Authors:  Supeecha Kumkate; Lawan Chanhome; Tipparat Thiangtrongjit; Jureeporn Noiphrom; Panithi Laoungboa; Orawan Khow; Taksa Vasaruchapong; Siravit Sitprija; Narongsak Chaiyabutr; Onrapak Reamtong
Journal:  Toxins (Basel)       Date:  2020-01-16       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.